Masimo W1 watch gets FDA clearance for OTC, prescription use

Nov. 17, 2023 6:10 PM ETMasimo Corporation (MASI)By: Val Brickates Kennedy, SA News Editor1 Comment

Headquarters of US Food and Drug Administration (FDA)


The FDA has cleared Masimo’s (NASDAQ:MASI) W1 medical watch for both prescription and over-the-counter use.

The watch provides continuous real-time oxygen saturation and pulse rate monitoring and is approved for use by adults in hospitals, clinics, long-term care facilities and at home.

Masimo said managing oxygen levels can be prescribed for patients recovering from surgery, managing chronic breathing conditions and with congenital heart failure.

Recommended For You

More Trending News

See More »

William Murphy

Related post